These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sulcus vocalis in spasmodic dysphonia-A retrospective study. Nerurkar NK; Agrawal D; Joshi D Am J Otolaryngol; 2021; 42(3):102940. PubMed ID: 33545449 [TBL] [Abstract][Full Text] [Related]
3. Listening: the key to diagnosing spasmodic dysphonia. Braden MN; Hapner ER ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236 [TBL] [Abstract][Full Text] [Related]
4. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia. Roy N; Gouse M; Mauszycki SC; Merrill RM; Smith ME Laryngoscope; 2005 Feb; 115(2):311-6. PubMed ID: 15689757 [TBL] [Abstract][Full Text] [Related]
5. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges. Barkmeier JM; Case JL; Ludlow CL J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal variations of laryngeal overpressure and voice-related quality of life in spasmodic dysphonia. Yeung JC; Fung K; Davis E; Rai SK; Day AM; Dzioba A; Bornbaum C; Doyle PC Laryngoscope; 2015 Mar; 125(3):661-6. PubMed ID: 25290557 [TBL] [Abstract][Full Text] [Related]
7. Voice Onset Time for the Word-Initial Voiceless Consonant /t/ in Japanese Spasmodic Dysphonia-A Comparison With Normal Controls. Yanagida S; Nishizawa N; Mizoguchi K; Hatakeyama H; Fukuda S J Voice; 2015 Jul; 29(4):450-4. PubMed ID: 25944292 [TBL] [Abstract][Full Text] [Related]
8. Impact of an Upper Respiratory Tract Infection on Botulinum Toxin Efficacy in Spasmodic Dysphonia Patients. Kirke DN; Kaye R; Blitzer A Laryngoscope; 2020 Jul; 130(7):1746-1749. PubMed ID: 31508822 [TBL] [Abstract][Full Text] [Related]
9. Influence of consonant voicing characteristics on sentence production in abductor versus adductor spasmodic dysphonia. Cannito MP; Chorna LB; Kahane JC; Dworkin JP J Voice; 2014 May; 28(3):394.e13-22. PubMed ID: 24440058 [TBL] [Abstract][Full Text] [Related]
10. Automated acoustic analysis of task dependency in adductor spasmodic dysphonia versus muscle tension dysphonia. Roy N; Mazin A; Awan SN Laryngoscope; 2014 Mar; 124(3):718-24. PubMed ID: 23946147 [TBL] [Abstract][Full Text] [Related]
11. Vibratory Onset of Adductor Spasmodic Dysphonia and Muscle Tension Dysphonia: A High-Speed Video Study✰. Chen W; Woo P; Murry T J Voice; 2020 Jul; 34(4):598-603. PubMed ID: 30595236 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of Onabotulinum Toxin A Treatment for Adductor Spasmodic Dysphonia and Laryngeal Tremor. Patel PN; Kabagambe EK; Starkweather JC; Keller M; Gamsarian V; Lee J; Kulkarni V; Garrett CG; Francis DO JAMA Otolaryngol Head Neck Surg; 2018 Apr; 144(4):293-299. PubMed ID: 29423509 [TBL] [Abstract][Full Text] [Related]
13. Laryngeal dystonia gravidarum: sudden onset of adductor spasmodic dysphonia in pregnancy. Ankola A; Sulica L; Murry T Laryngoscope; 2013 Dec; 123(12):3127-30. PubMed ID: 23712421 [TBL] [Abstract][Full Text] [Related]
14. Auditory Feedback Control Mechanisms Do Not Contribute to Cortical Hyperactivity Within the Voice Production Network in Adductor Spasmodic Dysphonia. Daliri A; Heller Murray ES; Blood AJ; Burns J; Noordzij JP; Nieto-Castanon A; Tourville JA; Guenther FH J Speech Lang Hear Res; 2020 Feb; 63(2):421-432. PubMed ID: 32091959 [TBL] [Abstract][Full Text] [Related]
15. Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies. Khan HA Cureus; 2023 Jan; 15(1):e33486. PubMed ID: 36628391 [TBL] [Abstract][Full Text] [Related]
16. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Simonyan K; Ludlow CL Cereb Cortex; 2010 Nov; 20(11):2749-59. PubMed ID: 20194686 [TBL] [Abstract][Full Text] [Related]
17. Laryngeal aerodynamic aspects of women with adductor spasmodic dysphonia. Sapienza CM; Crary MA; Gorham M Arch Otolaryngol Head Neck Surg; 1996 Apr; 122(4):385-8. PubMed ID: 8600922 [TBL] [Abstract][Full Text] [Related]
18. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin. Meyer TK; Hu A; Hillel AD Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277 [TBL] [Abstract][Full Text] [Related]
19. Validation of a telephone screening tool for spasmodic dysphonia and vocal fold tremor. Johnson DM; Hapner ER; Klein AM; Pethan M; Johns MM J Voice; 2014 Nov; 28(6):711-5. PubMed ID: 24962230 [TBL] [Abstract][Full Text] [Related]
20. The Influence of Linguistic Demand on Symptom Expression in Adductor Spasmodic Dysphonia. Froeschke LLO J Voice; 2020 Sep; 34(5):807.e11-807.e21. PubMed ID: 31047737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]